These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 9256135

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Retrospective comparison of single-agent chemotherapy with weekly 5-fluorouracil or weekly irinotecan in previously treated patients with metastatic colorectal cancer.
    Lavrenkov K, Man S, Mermershtain W, Cohen Y.
    J Chemother; 2002 Feb; 14(1):84-7. PubMed ID: 11892905
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. CPT-11 F205, F220, F221 and V222 study groups.
    Freyer G, Rougier P, Bugat R, Droz JP, Marty M, Bleiberg H, Mignard D, Awad L, Herait P, Culine S, Trillet-Lenoir V.
    Br J Cancer; 2000 Aug; 83(4):431-7. PubMed ID: 10945486
    [Abstract] [Full Text] [Related]

  • 10. Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy.
    Pitot HC, Goldberg RM, Reid JM, Sloan JA, Skaff PA, Erlichman C, Rubin J, Burch PA, Adjei AA, Alberts SA, Schaaf LJ, Elfring G, Miller LL.
    Clin Cancer Res; 2000 Jun; 6(6):2236-44. PubMed ID: 10873073
    [Abstract] [Full Text] [Related]

  • 11. Single-agent irinotecan as second-line weekly chemotherapy in elderly patients with advanced colorectal cancer.
    Rosati G, Cordio S.
    Tumori; 2006 Jun; 92(4):290-4. PubMed ID: 17036518
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Phase II trial of irinotecan in combination with amifostine in patients with advanced colorectal carcinoma.
    Delioukina ML, Prager D, Parson M, Hecht JR, Rosen P, Rosen LS.
    Cancer; 2002 Apr 15; 94(8):2174-9. PubMed ID: 12001114
    [Abstract] [Full Text] [Related]

  • 15. Irinotecan versus infusional 5-fluorouracil: a phase III study in metastatic colorectal cancer following failure on first-line 5-fluorouracil. V302 Study Group.
    Van Cutsem E, Blijham GH.
    Semin Oncol; 1999 Feb 15; 26(1 Suppl 5):13-20. PubMed ID: 10213010
    [Abstract] [Full Text] [Related]

  • 16. Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy.
    Nobili S, Checcacci D, Filippelli F, Del Buono S, Mazzocchi V, Mazzei T, Mini E.
    J Chemother; 2008 Oct 15; 20(5):622-31. PubMed ID: 19028627
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Phase II trial of 9-aminocamptothecin administered as a 72-hour continuous infusion in metastatic colorectal carcinoma.
    Pazdur R, Diaz-Canton E, Ballard WP, Bradof JE, Graham S, Arbuck SG, Abbruzzese JL, Winn R.
    J Clin Oncol; 1997 Aug 15; 15(8):2905-9. PubMed ID: 9256134
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience.
    Comella P, Massidda B, Natale D, Putzu C, Sandomenico C, Filippelli G, Palmeri S, Condemi G, Vessia G, Barberis G, Ionta MT, Tafuto S, Barbato E.
    Clin Colorectal Cancer; 2011 Mar 01; 10(1):42-7. PubMed ID: 21609935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.